Earn credit at your own pace through October 16, 2025 and continue to access your videos until October 16, 2032. See below for detailed information and learning outcomes.
This course offers 4 CME following completion of an online test.
Video content for this Online Course will be available to view until October 16, 2032, which is ten years following the issuance date of this course. ARRS reserves the right to remove video content before the end of the ten year period. Video content that contradicts current science or misleads the viewer based on changes to accepted clinical practice may be removed on a case-by-case basis.
Learning Outcomes and Modules
After completing this course, the learner should be able to:
- Apply LI-RADS diagnostic criteria in patients at risk for HCC.
- Implement dual-energy CT in clinical practice for liver and pancreatic tumor imaging.
- Compare advantages of different MRI protocols for liver imaging.
- Revisit cancer risk of incidentally detected gallbladder polyps and review new SRU consensus statement recommendations.
- LI-RADS: Beauty and the Beast—Victoria Chernyak, MD, MS
- Pancreas Cancer Staging and Response Assessment—Shannan Dickinson, MD
- Rethinking Gallbladder Polyps and Cancer Risk—Aya Kamaya, MD
- Should I use DECT for my Liver and Pancreas Protocol CT?—Avinash Kambadakone, MD
- Optimizing your Liver MRI Protocol—Benjamin Wildman-Tobriner, MD
- Imaging Tumors of the Biliary Tract: An Update—Andrea Siobhan Kierans, MD
- Reporting Standards for Primary Sclerosing Cholangitis using MRI—Sudhakar Venkatesh, MD
- Tying it all Together: Challenging HPB Cases—Richard Gian Do, MD, PhD
ARRS is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education activities for physicians.
The ARRS designates this enduring material for a maximum of 4.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
View the ARRS Return Policy.